Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 50, 59-100

Live Attenuated Varicella Vaccine

Affiliations
Review

Live Attenuated Varicella Vaccine

A M Arvin et al. Annu Rev Microbiol.

Abstract

Varicella-zoster virus (VZV) is a ubiquitous human pathogen that causes varicella, commonly called chicken pox; establishes latency; and reactivates as herpes zoster, referred to as shingles. A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella. The vaccine induces persistent immunity to VZV in healthy children and adults. Immunization against VZV also has the potential to lower the risk of reactivation of latent virus. The varicella vaccine may eventually reduce or eliminate herpes zoster, which is a serious problem for elderly and immunocompromised individuals.

Similar articles

See all similar articles

Cited by 16 articles

See all "Cited by" articles

LinkOut - more resources

Feedback